04 Sept 2020
The new drug, somapacitan, has been approved by the US Food and Drug Administration as a replacement growth hormone in adults with growth hormone deficiency and is the first drug that can be administered weekly, rather than daily.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024